☆ 4.2 Article

Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Related references

Note: Only part of the references are listed.

Review Neurosciences

Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The Literature

Katarina Dakay et al.

Summary: SARS-CoV-2 infection has been linked to various hematologic abnormalities, with a notably high incidence of venous thromboembolism, including cerebral venous sinus thrombosis (cVST) which has been less commonly reported in association with COVID-19 and tends to occur more frequently in women and young individuals.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)

Add to Collection

Article Hematology

A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination

Stefan Handtke et al.

Summary: Vaccination plays a crucial role in combating the pandemic caused by the SARS-CoV-2 virus. The rare complication of thrombocytopenia and thrombotic complications after ChAdOx1 nCov-19 vaccination can be identified using a widely applicable whole-blood standard flow cytometric assay, allowing for rapid diagnosis by many laboratories.

BLOOD (2021)

Add to Collection

Editorial Material Hematology

Post-mortem findings in vaccine-induced thrombotic thombocytopenia

Cristoforo Pomara et al.

HAEMATOLOGICA (2021)

Add to Collection

Article Hematology

Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)

Johannes Thaler et al.

Summary: In cases of VIPIT following ChAdOx1 nCoV-19 vaccination, early initiation of treatment can effectively reduce the risk of thrombosis and lead to rapid improvement in the patient's health without thrombotic complications.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Medicine, General & Internal

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

Marie Scully et al.

Summary: 23 cases of thrombotic thrombocytopenia were reported after receiving the AstraZeneca vaccine, incited by antibodies to platelet factor 4 and unrelated to heparin therapy. Avoidance of platelet transfusion and consideration of nonheparin anticoagulant and intravenous immune globulin are recommended for treatment.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

Nina H. Schultz et al.

Summary: This study reports five cases of venous thrombosis and thrombocytopenia occurring 7 to 10 days after receiving the ChAdOx1 nCoV-19 vaccine, suggesting a rare vaccine-induced immune thrombotic thrombocytopenia. The condition, which can lead to catastrophic outcomes such as cerebral venous sinus thrombosis, may be treated with intravenous immune globulin.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Add to Collection

Letter Infectious Diseases

An interactive web-based dashboard to track COVID-19 in real time

Ensheng Dong et al.

LANCET INFECTIOUS DISEASES (2020)

Add to Collection

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow

Behnood Bikdeli et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Review Clinical Neurology

COVID-19: A Global Threat to the Nervous System

Igor J. Koralnik et al.

ANNALS OF NEUROLOGY (2020)

Add to Collection

Article Hematology

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

Corrado Lodigiani et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Maheshi N. Ramasamy et al.

LANCET (2020)

Add to Collection

Review Cell Biology

Coronavirus vaccine development: from SARS and MERS to COVID-19

Yen-Der Li et al.

JOURNAL OF BIOMEDICAL SCIENCE (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.